Literature DB >> 1884116

Kinetics of (+)-tubocurarine blockade at the neuromuscular junction.

A C Le Dain1, B W Madsen, R O Edeson.   

Abstract

1. Although (+)-tubocurarine (Tc) is classically considered to be a competitive antagonist at the neuromuscular junction, kinetic details of the interaction remain unclear. 2. We studied the competitive action of Tc on the nicotinic receptor at the frog neuromuscular junction using a quantitative analysis of the generation phase of miniature endplate currents (m.e.p.cs) recorded in Ringer solution (20 degrees C) under voltage clamp (-90 mV) in the absence or presence of 1-5 microM Tc. Under control conditions four neurotransmission parameters were estimated by non-linear regression using a mathematical model of synaptic transmission incorporating transmitter release, diffusion, hydrolysis, receptor binding and channel gating. These parameters were then used in a further regression to estimate binding rate constants for Tc at the same endplate. Allowance was made for open channel block by Tc, which under the conditions of this study was only a small component of total blockade. 3. The results suggest that Tc binds to the two agonist recognition sites on the nicotinic receptor with equal affinity (stoichiometric KDs of 2.2 and 8.8 microM), and that most of the functional blockade at concentrations up to 5 microM is due to occupancy of only one site. 4. The association rate constant for Tc binding to sites on the nicotinic acetylcholine receptor appears to be very fast (k+D = 8.9 x 10(8) M-1 s-1) and comparable to that for acetylcholine (ACh). 5. In the brief time during which an m.e.p.c. is generated (approximately 200 microseconds, reversal of Tc blockade by transiently high concentrations of ACh seems to be kinetically limited.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884116      PMCID: PMC1908381          DOI: 10.1111/j.1476-5381.1991.tb09835.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  The antagonism between tubocurarine and substances which depolarize the motor end-plate.

Authors:  D H JENKINSON
Journal:  J Physiol       Date:  1960-07       Impact factor: 5.182

2.  The actions of tubocurarine at the frog neuromuscular junction.

Authors:  D Colquhoun; F Dreyer; R E Sheridan
Journal:  J Physiol       Date:  1979-08       Impact factor: 5.182

3.  A study of the irreversible cholinesterase inhibitor, diisopropylfluorophosphate, on time course of end-plate currents in frog sartorius muscle.

Authors:  K Kuba; E X Albuquerque; J Daly; E A Barnard
Journal:  J Pharmacol Exp Ther       Date:  1974-05       Impact factor: 4.030

Review 4.  Pharmacological receptors.

Authors:  D R Waud
Journal:  Pharmacol Rev       Date:  1968-06       Impact factor: 25.468

5.  Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor.

Authors:  S M Sine; P Taylor
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

6.  Ligand specificity of state transitions in the cholinergic receptor: behavior of agonists and antagonists.

Authors:  G Weiland; P Taylor
Journal:  Mol Pharmacol       Date:  1979-03       Impact factor: 4.436

7.  A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones.

Authors:  M Benveniste; J Clements; L Vyklický; M L Mayer
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

8.  Mechanism of gating of T-type calcium channels.

Authors:  C F Chen; P Hess
Journal:  J Gen Physiol       Date:  1990-09       Impact factor: 4.086

9.  Ligand-induced conformation changes in Torpedo californica membrane-bound acetylcholine receptor.

Authors:  U Quast; M Schimerlik; T Lee; T L Witzemann; S Blanchard; M A Raftery
Journal:  Biochemistry       Date:  1978-06-13       Impact factor: 3.162

10.  Equilibrium binding of [3H]tubocurarine and [3H]acetylcholine by Torpedo postsynaptic membranes: stoichiometry and ligand interactions.

Authors:  R R Neubig; J B Cohen
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  2 in total

1.  An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.

Authors:  J H Proost; J M Wierda; D K Meijer
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

2.  Physiologic-pharmacologic interpretation of the constants in the Hill equation for neuromuscular block: a hypothesis.

Authors:  Vladimir Nigrovic; Anton Amann
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.